| Value | ₹15.10 Cr |
|---|
NSE filing, NSE: SUNREST. Summary written from the filing by ALFA Finder's alert engine.
Sunrest Lifescience Ltd: key numbers
- Share price
- ₹33.50
- Market cap
- ₹28.75 Cr
- Revenue (annual)
- ₹70.83 Cr
- Net profit (annual)
- ₹4.12 Cr
- P/E (TTM)
- 7.0×Sector 48.7×
- Promoter holding
- 53.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sunrest Lifescience Ltd
All →Sunrest Lifescience Other Announcement
Sunrest Lifescience submitted a certificate confirming the non-applicability of corporate governance reporting requirements for the quarter ended 30th September 2026, due to its SME listing.
Sunrest Lifescience Board Meeting Outcome
Sunrest Lifescience Limited has cancelled its Rights Issue due to the non-receipt of the minimum subscription required by SEBI regulations.
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience held its 9th AGM on 7 Sep 2026 via VC/OAVM. Resolutions covered adoption of FY26 financials, re-appointment of MD and WTD, and related-party transaction approval.
Sunrest Lifescience Capital Structure Change
Sunrest Lifescience Limited has extended its ongoing Rights Issue by nine days, with the new closing date set for September 11, 2026.
Sunrest Lifescience Business Update
Sunrest Lifescience Limited's subsidiary, Hetvi Lifesciences, is executing a ₹9.22 Crore order from Gujarat Medical Services Corporation Limited. ₹80.76 Lakhs worth of work is completed.
- Value
- ₹9.22 Cr
Sunrest Lifescience Annual General Meeting
Sunrest Lifescience Limited has issued a notice for its Annual General Meeting scheduled for September 7, 2026, to transact various ordinary and special businesses.
- Value
- ₹10.00 Cr
Other fund raise announcements
All →Gujarat Inject (Kerala) Fund Raise of ₹3 Cr
Gujarat Inject Kerala's board approved a Rs.3 Crore preferential warrant issue to public investors. Authorised capital will rise to Rs.17.63 Crore, subject to shareholder approval.
- Value
- ₹3.00 Cr
MosChip Technologies Fund Raise of ₹112.2 Cr
MosChip Technologies approved a preferential issue of 50,50,686 equity shares at Rs.222 to 69 investors, raising about Rs.112.19 Crore. The board approval covers the fund raise, with an AGM/postal ballot dated 25 November 2026.
- Value
- ₹112.2 Cr
Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.
Bodhi Tree Multimedia Fund Raise
Bodhi Tree Multimedia's EOGM on October 28, 2026, sought approval for a qualified institutions placement. The filing states no issue size.
Avalon Technologies Fund Raise of ₹425 Cr
Avalon Technologies' board approved a preferential warrant issue to Zollner Elektronik AG worth about ₹425 Crore. Shareholder approval is required at an EGM on 21 November 2026.
- Value
- ₹425.0 Cr
- Execution
- Warrants exercisable within 18 months from allotment
Sealmatic India Fund Raise of ₹15.01 Cr
Sealmatic India's board approved a ₹15.01 Crore preferential issue of 3,61,620 equity shares at ₹415 to two non-promoter investors. Shareholder approval at EGM is pending.
- Value
- ₹15.01 Cr